financetom
Business
financetom
/
Business
/
FinVolution Group Q2 Non-GAAP Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FinVolution Group Q2 Non-GAAP Earnings, Revenue Increase
Aug 21, 2024 1:44 AM

03:54 AM EDT, 08/21/2024 (MT Newswires) -- FinVolution Group ( FINV ) reported Q2 non-GAAP earnings late Tuesday of 0.44 Chinese renminbi ($0.06) per diluted share, up from 0.41 renminbi a year earlier.

Net revenue for the quarter ended June 30 was 3.17 billion renminbi, up from 3.08 billion renminbi a year earlier.

Analyst estimates were not readily available for comparison.

Price: 5.57, Change: -0.13, Percent Change: -2.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Commerce Bancshares Insider Sold Shares Worth $1,509,070, According to a Recent SEC Filing
Commerce Bancshares Insider Sold Shares Worth $1,509,070, According to a Recent SEC Filing
May 14, 2024
10:51 AM EDT, 05/14/2024 (MT Newswires) -- John W Kemper, Director, President and CEO, on May 10, 2024, sold 26,581 shares in Commerce Bancshares ( CBSH ) for $1,509,070. Following the Form 4 filing with the SEC, Kemper has control over a total of 456,067 shares of the company, with 198,387 shares held directly and 257,680 controlled indirectly. SEC Filing:...
Container Store Gets NYSE Notice of Noncompliance
Container Store Gets NYSE Notice of Noncompliance
May 14, 2024
10:47 AM EDT, 05/14/2024 (MT Newswires) -- Container Store ( TCS ) said Tuesday the New York Stock Exchange has notified the company of its noncompliance with the exchange's continued listing requirements as the average closing price of its stock was less than $1 over a 30-day period. The company said it plans to cure the stock price deficiency and...
Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise
Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise
May 14, 2024
10:46 AM EDT, 05/14/2024 (MT Newswires) -- Calliditas Therapeutics ( CALT ) said Tuesday its partner Everest Medicines is offering Nefecon in China. China's National Medical Products Administration granted conditional approval for Nefecon in November 2023 as a treatment for IgA nephropathy, the progressive autoimmune disease, the company said. Nefecon is also approved in Macau, Hong Kong and Singapore, Calliditas...
What's Going On With BlackBerry Stock Today?
What's Going On With BlackBerry Stock Today?
May 14, 2024
BlackBerry Ltd ( BB ) stock is trading higher Tuesday following a meme posted on social media earlier this week. The Details: BlackBerry shares are up Tuesday after Keith Gill, also known as “Roaring Kitty” on Youtube or X, posted a meme on Monday of a person leaning forward while sitting in a chair, breaking three years of silence. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved